Literature DB >> 10655090

IgG surfaces as an important component in mucosal protection.

M Robert-Guroff.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 10655090     DOI： 10.1038/72206

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  24 in total

1.  Neonatal Fc receptor for IgG regulates mucosal immune responses to luminal bacteria.

Authors:  Masaru Yoshida; Kanna Kobayashi; Timothy T Kuo; Lynn Bry; Jonathan N Glickman; Steven M Claypool; Arthur Kaser; Takashi Nagaishi; Darren E Higgins; Emiko Mizoguchi; Yoshio Wakatsuki; Derry C Roopenian; Atsushi Mizoguchi; Wayne I Lencer; Richard S Blumberg
Journal:  J Clin Invest       Date:  2006-08       Impact factor: 14.808

2.  IgG transport across mucosal barriers by neonatal Fc receptor for IgG and mucosal immunity.

Authors:  Masaru Yoshida; Atsuhiro Masuda; Timothy T Kuo; Kanna Kobayashi; Steven M Claypool; Tetsuya Takagawa; Hiromu Kutsumi; Takeshi Azuma; Wayne I Lencer; Richard S Blumberg
Journal:  Springer Semin Immunopathol       Date:  2006-10-19

3.  Humoral immune responses and protective efficacy of sequential B- and T-cell epitopes of V antigen of Yersinia pestis by intranasal immunization in microparticles.

Authors:  Jayaprakash Babu Uppada; Arif Azam Khan; Ajaz Ahmad Bhat; Ranjana Deshmukh; Donthamsetty Nageswara Rao
Journal:  Med Microbiol Immunol       Date:  2009-09-25       Impact factor: 3.402

4.  Transient antibody-mucin interactions produce a dynamic molecular shield against viral invasion.

Authors:  Alex Chen; Scott A McKinley; Simi Wang; Feng Shi; Peter J Mucha; M Gregory Forest; Samuel K Lai
Journal:  Biophys J       Date:  2014-05-06       Impact factor: 4.033

5.  Protection against simian immunodeficiency virus vaginal challenge by using Sabin poliovirus vectors.

Authors:  S Crotty; C J Miller; B L Lohman; M R Neagu; L Compton; D Lu; F X Lü; L Fritts; J D Lifson; R Andino
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

6.  Co-delivery of GPI-anchored CCL28 and influenza HA in chimeric virus-like particles induces cross-protective immunity against H3N2 viruses.

Authors:  Teena Mohan; Jongrok Kim; Zachary Berman; Shelly Wang; Richard W Compans; Bao-Zhong Wang
Journal:  J Control Release       Date:  2016-05-10       Impact factor: 9.776

7.  Cellular immunity elicited by human immunodeficiency virus type 1/ simian immunodeficiency virus DNA vaccination does not augment the sterile protection afforded by passive infusion of neutralizing antibodies.

Authors:  John R Mascola; Mark G Lewis; Thomas C VanCott; Gabriela Stiegler; Hermann Katinger; Michael Seaman; Kristin Beaudry; Dan H Barouch; Birgit Korioth-Schmitz; Georgia Krivulka; Anna Sambor; Brent Welcher; Daniel C Douek; David C Montefiori; John W Shiver; Pascal Poignard; Dennis R Burton; Norman L Letvin
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  HIV Infection and Gut Mucosal Immune Function: Updates on Pathogenesis with Implications for Management and Intervention.

Authors:  Barbara L Shacklett; Peter A Anton
Journal:  Curr Infect Dis Rep       Date:  2010-01-13       Impact factor: 3.725

9.  Improved protection of rhesus macaques against intrarectal simian immunodeficiency virus SIV(mac251) challenge by a replication-competent Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinant priming/gp120 boosting regimen.

Authors:  Jun Zhao; Joel Pinczewski; Victor R Gómez-Román; David Venzon; V S Kalyanaraman; Phillip D Markham; Kristine Aldrich; Matthew Moake; David C Montefiori; Yuanmei Lou; George N Pavlakis; Marjorie Robert-Guroff
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

10.  Assessment of oral transmission using cell-free human immunodeficiency virus-1 in mice reconstituted with human peripheral blood leucocyte.

Authors:  Ryoma Nakao; Nobuhiro Hanada; Toshihiko Asano; Takashi Hara; Md Abdus Salam; Khairul Matin; Yoshihito Shimazu; Tadashi Nakasone; Shigeo Horibata; Takaaki Aoba; Mitsuo Honda; Teruo Amagasa; Hidenobu Senpuku
Journal:  Immunology       Date:  2003-06       Impact factor: 7.397
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.